These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23900414)

  • 1. Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells.
    Kaulfuß S; Seemann H; Kampe R; Meyer J; Dressel R; König B; Scharf JG; Burfeind P
    Oncotarget; 2013 Jul; 4(7):1037-49. PubMed ID: 23900414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.
    Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT
    J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo.
    Nishioka C; Ikezoe T; Yang J; Miwa A; Tasaka T; Kuwayama Y; Togitani K; Koeffler HP; Yokoyama A
    Blood; 2008 May; 111(10):5086-92. PubMed ID: 18309036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet‑derived growth factor receptor‑β gene expression relates to recurrence in colorectal cancer.
    Fujino S; Miyoshi N; Ohue M; Takahashi Y; Yasui M; Hata T; Matsuda C; Mizushima T; Doki Y; Mori M
    Oncol Rep; 2018 May; 39(5):2178-2184. PubMed ID: 29498405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.
    Moench R; Gasser M; Nawalaniec K; Grimmig T; Ajay AK; de Souza LCR; Cao M; Luo Y; Hoegger P; Ribas CM; Ribas-Filho JM; Malafaia O; Lissner R; Hsiao LL; Waaga-Gasser AM
    Oncotarget; 2022 Oct; 13():1140-1152. PubMed ID: 36264073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
    Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
    Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
    Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
    Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
    Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
    Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
    Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib.
    Coluccia AM; Cirulli T; Neri P; Mangieri D; Colanardi MC; Gnoni A; Di Renzo N; Dammacco F; Tassone P; Ribatti D; Gambacorti-Passerini C; Vacca A
    Blood; 2008 Aug; 112(4):1346-56. PubMed ID: 18524994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
    Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The platelet-derived growth factor receptor-beta phosphorylates and activates G protein-coupled receptor kinase-2. A mechanism for feedback inhibition.
    Wu JH; Goswami R; Kim LK; Miller WE; Peppel K; Freedman NJ
    J Biol Chem; 2005 Sep; 280(35):31027-35. PubMed ID: 15994317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer.
    Kim SJ; Noh TH; Son S; Kim DH; Kim W; Lee Y; Choo J; Heo G; Kim MJ; Chung HY; Jung Y; Jung JH; Moon HR; Im E
    Cell Death Dis; 2018 Aug; 9(9):877. PubMed ID: 30158525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the non-receptor tyrosine kinase ACK1 in TNF-alpha-mediated apoptosis and proliferation in human intestinal epithelial caco-2 cells.
    Zhao X; Lv C; Chen S; Zhi F
    Cell Biol Int; 2018 Sep; 42(9):1097-1105. PubMed ID: 28921811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
    Ruan J; Luo M; Wang C; Fan L; Yang SN; Cardenas M; Geng H; Leonard JP; Melnick A; Cerchietti L; Hajjar KA
    Blood; 2013 Jun; 121(26):5192-202. PubMed ID: 23632889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.